EUVIMEDEUVIMED entdecken
Crossref

The Diagnostic Significance of Circulating Eicosanoid in Patients with Hypertrophic Cardiomyopathy

Yue Zhang, Xinyu Liu, Zhongze Zhang, Weiyan Sun, Wenjing Yue, Le Liu, Yi Zhu, Xu Zhang, Hong Wang iD

Journal of Cardiovascular Translational Research · 2025

DOI: 10.1007/s12265-025-10652-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Translational Research, 2025. Verfasst von Yue Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Metabolic Diseases, The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Center …. Hauptthemen laut MEDLINE: Eicosanoids, Cardiomyopathy, Hypertrophic, Metabolomics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic cardiomyopathy (HCM) is one of the most prevalent hereditary cardiovascular diseases. Eicosanoids are known to play a significant role in cardiovascular diseases and serve as biomarkers. In this study, plasma eicosanoids were profiled by LC-MS in a cohort of 78 healthy individuals and 73 patients diagnosed with HCM. Our findings reveal HCM patients exhibit downregulation of various eicosanoids, including AA, 5,6-DHET, 12-HETE, LXA4, EPA, etc. Notably, the combined predictive model incorporating 12-HETE and EPA demonstrates significant diagnostic value for HCM. Additionally, ten closely related metabolites showed significant positive correlations within the metabolic network graph. Eicosanoids such as 17,18-EEQ, LXA4, and 13-oxo-ODE exhibit significant negative correlations with plasma concentrations of hs-CRP and NT-proBNP in patients. Alterations in eicosanoid metabolism may be implicated in the pathophysiological processes underlying HCM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EicosanoidsCardiomyopathy, HypertrophicMetabolomicsHumansBiomarkersMaleFemaleMiddle AgedPredictive Value of TestsCase-Control StudiesAdultChromatography, LiquidAged

Stichwörter der Autor:innen

BiomarkersEicosanoidsHypertrophic cardiomyopathyMetabolomics

Substanzen

BiomarkersEicosanoids

Autor:innen und Institutionen

  • Tianjin Key Laboratory of Metabolic Diseases, The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Center for Cardiovascular Diseases, Research Center of Basic Medical Sciences…
  • Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology and Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiologi…

ORCID-Profile: Hong Wang

Förderung

  • National Natural Science Foundation

Zitieren

APA

Zhang, Y., Liu, X., Zhang, Z., Sun, W., Yue, W., Liu, L., Zhu, Y., Zhang, X., & Wang, H. (2025). The Diagnostic Significance of Circulating Eicosanoid in Patients with Hypertrophic Cardiomyopathy. Journal of Cardiovascular Translational Research. https://doi.org/10.1007/s12265-025-10652-9

Vancouver

Zhang Y, Liu X, Zhang Z, Sun W, Yue W, Liu L, et al. The Diagnostic Significance of Circulating Eicosanoid in Patients with Hypertrophic Cardiomyopathy. Journal of Cardiovascular Translational Research. 2025. doi:10.1007/s12265-025-10652-9

BibTeX
@article{Zhang2025,
  author = {Zhang, Yue and Liu, Xinyu and Zhang, Zhongze and Sun, Weiyan and Yue, Wenjing and Liu, Le and Zhu, Yi and Zhang, Xu and Wang, Hong},
  title = {The Diagnostic Significance of Circulating Eicosanoid in Patients with Hypertrophic Cardiomyopathy},
  journal = {Journal of Cardiovascular Translational Research},
  year = {2025},
  doi = {10.1007/s12265-025-10652-9}
}
Kostenlos starten →